Nicola L. Beer

ORCID: 0000-0002-4964-7150
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic function and diabetes
  • Genetic Associations and Epidemiology
  • Metabolism, Diabetes, and Cancer
  • Diabetes and associated disorders
  • Diabetes Management and Research
  • Genetics and Neurodevelopmental Disorders
  • Bioinformatics and Genomic Networks
  • Diabetes Treatment and Management
  • Pluripotent Stem Cells Research
  • Genomics and Rare Diseases
  • Epigenetics and DNA Methylation
  • CRISPR and Genetic Engineering
  • Endoplasmic Reticulum Stress and Disease
  • Liver Disease Diagnosis and Treatment
  • Genetic Mapping and Diversity in Plants and Animals
  • Nutrition, Genetics, and Disease
  • Cardiovascular Disease and Adiposity
  • Adipokines, Inflammation, and Metabolic Diseases
  • Analog and Mixed-Signal Circuit Design
  • COVID-19 Clinical Research Studies
  • PARP inhibition in cancer therapy
  • Adipose Tissue and Metabolism
  • Diet, Metabolism, and Disease
  • MicroRNA in disease regulation
  • Cancer-related gene regulation

University of Oxford
2012-2025

Centre for Human Genetics
2019-2025

Oxford Centre for Diabetes, Endocrinology and Metabolism
2012-2024

Novo Nordisk (United Kingdom)
2019-2021

Novo Nordisk (Denmark)
2021

Churchill Hospital
2011-2018

Broad Institute
2012-2014

Massachusetts Institute of Technology
2013

Christian Fuchsberger Jason Flannick Tanya M. Teslovich Anubha Mahajan Vineeta Agarwala and 95 more Kyle J. Gaulton Clement Ma Pierre Fontanillas Loukas Moutsianas Davis J. McCarthy Manuel A. Rivas John R. B. Perry Xueling Sim Thomas W. Blackwell Neil R. Robertson Nigel W. Rayner Pablo Cingolani Adam E. Locke Juan Fernández Tajes Heather M. Highland Josée Dupuis Peter S. Chines Cecilia M. Lindgren Christopher Hartl Anne Jackson Han Chen Jeroen R. Huyghe Martijn van de Bunt Richard D. Pearson Ashish Kumar Martina Müller‐Nurasyid Niels Grarup Heather M. Stringham Eric R. Gamazon Jaehoon Lee Yuhui Chen Robert A. Scott Jennifer E. Below Peng Chen Jinyan Huang Min Jin Go Michael L. Stitzel Dorota Pasko Stephen C. J. Parker Tibor V. Varga Todd Green Nicola L. Beer Aaron G. Day‐Williams Teresa Ferreira Tasha E. Fingerlin Momoko Horikoshi Cheng Hu Iksoo Huh M. Kamran Ikram Bong-Jo Kim Yongkang Kim Young Jin Kim Min‐Seok Kwon Juyoung Lee Selyeong Lee Keng‐Han Lin Taylor J. Maxwell Yoshihiko Nagai Xu Wang Ryan Welch Joon Yoon Weihua Zhang Nir Barzilai Benjamin F. Voight Bok‐Ghee Han Christopher P. Jenkinson Teemu Kuulasmaa Johanna Kuusisto Alisa K. Manning Maggie C. Y. Ng Colin N. A. Palmer Beverley Balkau Alena Stančáková Hanna E. Abboud Heiner Boeing Vilmantas Giedraitis Dorairaj Prabhakaran Omri Gottesman Berthold Lausen Jason Carey Phoenix Kwan George Grant Joshua D. Smith Benjamin M. Neale Shaun Purcell Adam S. Butterworth Joanna M. M. Howson Heung Man Lee Yingchang Lu Soo‐Heon Kwak Wei Zhao John Danesh Vincent K. Lam Kyong Soo Park Danish Saleheen

10.1038/nature18642 article EN Nature 2016-07-11

10.1038/ng.2915 article EN Nature Genetics 2014-03-02
Kyle J. Gaulton Teresa Ferreira Yeji Lee Anne Raimondo Reedik Mägi and 95 more Michael E. Reschen Anubha Mahajan Adam E. Locke Nigel W. Rayner Neil Robertson Robert A. Scott Inga Prokopenko Laura J. Scott Todd Green Thomas Sparsø Dorothée Thuillier Loïc Yengo Harald Grallert Simone Wahl Mattias Frånberg Rona J. Strawbridge Hans A. Kestler Himanshu Chheda Lewin Eisele Stefan Gustafsson Valgerður Steinthórsdóttir Guðmar Þorleifsson Lu Qi Lennart C. Karssen Jin‐Moo Lee Sara M. Willems Man Li Han Chen Christian Fuchsberger Phoenix Kwan Clement Ma Michael D. Linderman Yingchang Lu Soren K. Thomsen Jana K. Rundle Nicola L. Beer Martijn van de Bunt Anil Chalisey Hyun Min Kang Benjamin F. Voight Gonçalo R. Abecasis Peter Almgren Damiano Baldassarre Beverley Balkau Rafn Benediktsson Matthias Blüher Heiner Boeing Lori L. Bonnycastle Erwin P. Böttinger Noël P. Burtt Jason Carey G. Charpentier Peter S. Chines Marilyn C. Cornelis David Couper Andrew Crenshaw Rob M. van Dam Alex S. F. Doney Mozhgan Dorkhan Sarah Edkins Johan G. Eriksson Tõnu Esko Elodie Eury João Fadista Jason Flannick Pierre Fontanillas Caroline S. Fox Paul W. Franks Karl Gertow Christian Gieger Bruna Gigante Omri Gottesman George Grant Niels Grarup Christopher J. Groves Maija Hassinen Henri Theil Christian Herder Oddgeir L. Holmen Ástráður B. Hreiðarsson Steve E. Humphries Sarah Hunt Anne Jackson Anna Jonsson Marit E. Jørgensen Torben Jørgensen Wen‐Hong L. Kao Nicola D. Kerrison Leena Kinnunen Norman Klopp Augustine Kong Péter Kovács Peter Kraft Jasmina Kravić Cordelia Langford

10.1038/ng.3437 article EN Nature Genetics 2015-11-09

Genome-wide association studies have identified a number of signals for both Type 2 Diabetes and related quantitative traits. For the majority loci, transition from signal to mutational mechanism has been difficult establish. Glucokinase (GCK) regulates glucose storage disposal in liver where its activity is regulated by glucokinase regulatory protein (GKRP; gene name GCKR ). Fructose-6 fructose-1 phosphate (F6P F1P) enhance or reduce GKRP-mediated inhibition, respectively. A common variant...

10.1093/hmg/ddp357 article EN Human Molecular Genetics 2009-07-30

To decipher the populations of cells present in human fetal pancreas and their lineage relationships, we developed strategies to isolate pancreatic progenitors, endocrine progenitors cells. Transcriptome analysis individual revealed a large degree conservation among vertebrates drivers gene expression changes occurring at different steps differentiation, although notably, sometimes, members same family are expressed. The transcriptome establishes resource identify novel genes pathways...

10.1242/dev.165480 article EN publisher-specific-oa Development 2018-01-01

Translation of genetic association signals into molecular mechanisms for diabetes has been slow. The glucokinase regulatory protein (GKRP; gene symbol GCKR) P446L variant, associated with inverse modulation glucose- and lipid-related traits, shown to alter the kinetics (GCK) inhibition. As GCK inhibition is nuclear sequestration, we aimed determine whether this variant also alters direct interaction between GKRP their intracellular localisation.Fluorescently tagged rat human wild-type (WT)-...

10.1007/s00125-011-2348-5 article EN cc-by-nc Diabetologia 2011-10-24

Several distinct differentiation protocols for deriving pancreatic progenitors (PPs) from human pluripotent stem cells have been described, but it remains to be shown how similar the PPs are across and well they resemble their in vivo counterparts. Here, we evaluated three protocols, performed RNA assay transposase-accessible chromatin using sequencing on isolated derived with these, compared them fetal pancreas populations. This enabled us define a shared transcriptional epigenomic...

10.1016/j.stemcr.2019.11.010 article EN cc-by Stem Cell Reports 2019-12-26

Abstract To enable robust expression of transgenes in stem cells, recombinase-mediated cassette exchange at safe harbor loci is frequently adopted. The choice recombinase enzyme a critical parameter to ensure maximum efficiency and accuracy the integration event. We have explored serine family site-specific integrases directly compared PhiC31, W-beta, Bxb1 integrase for targeted transgene Gt(ROSA)26Sor locus mouse embryonic cells. All 3 were found be suitable efficient engineering long-term...

10.1093/stmcls/sxae092 article EN cc-by Stem Cells 2025-01-01

Defining the genetic contribution of rare variants to common diseases is a major basic and clinical science challenge that could offer new insights into disease etiology provide potential for directed gene- pathway-based prevention treatment. Common nonsynonymous in GCKR gene are associated with alterations metabolic traits, most notably serum triglyceride levels. encodes glucokinase regulatory protein (GKRP), predominantly nuclear inhibits hepatic (GCK) plays critical role glucose...

10.1172/jci46425 article EN Journal of Clinical Investigation 2011-12-19
Jason Flannick Christian Fuchsberger Anubha Mahajan Tanya M. Teslovich Vineeta Agarwala and 95 more Kyle J. Gaulton Lizz Caulkins Ryan Koesterer Clement Ma Loukas Moutsianas Davis J. McCarthy Manuel A. Rivas John R. B. Perry Xueling Sim Thomas W. Blackwell Neil R. Robertson Nigel W. Rayner Pablo Cingolani Adam E. Locke Juan Fernández Tajes Heather M. Highland Josée Dupuis Peter S. Chines Cecilia M. Lindgren Christopher Hartl Anne Jackson Han Chen Jeroen R. Huyghe Martijn van de Bunt Richard D. Pearson Ashish Kumar Martina Müller‐Nurasyid Niels Grarup Heather M. Stringham Eric R. Gamazon Jaehoon Lee Yuhui Chen Robert A. Scott Jennifer E. Below Peng Chen Jinyan Huang Min Jin Go Michael L. Stitzel Dorota Pasko Stephen C. J. Parker Tibor V. Varga Todd J. Green Nicola L. Beer Aaron G. Day‐Williams Teresa Ferreira Tasha E. Fingerlin Momoko Horikoshi Cheng Hu Iksoo Huh M. Kamran Ikram Bong-Jo Kim Yongkang Kim Young Jin Kim Min‐Seok Kwon Juyoung Lee Selyeong Lee Keng-Han Lin Taylor J. Maxwell Yoshihiko Nagai Xu Wang Ryan Welch Joon Yoon Weihua Zhang Nir Barzilai Benjamin F. Voight Bok-Ghee Han Christopher P. Jenkinson Teemu Kuulasmaa Johanna Kuusisto Alisa K. Manning Maggie Ng Colin N. A. Palmer Beverley Balkau Alena Stančáková Hanna E. Abboud Heiner Boeing Vilmantas Giedraitis Dorairaj Prabhakaran Omri Gottesman Berthold Lausen Jason Carey Phoenix Kwan George Grant Joshua D. Smith Benjamin M. Neale Shaun Purcell Adam S. Butterworth Joanna M. M. Howson Heung Man Lee Yingchang Lu Soo-Heon Kwak Wei Zhao John Danesh Vincent K. Lam Kyong Soo Park

To investigate the genetic basis of type 2 diabetes (T2D) to high resolution, GoT2D and T2D-GENES consortia catalogued variation from whole-genome sequencing 2,657 European individuals exome 12,940 multiple ancestries. Over 27M SNPs, indels, structural variants were identified, including 99% low-frequency (minor allele frequency [MAF] 0.1-5%) non-coding in sequenced 99.7% coding whole-exome individuals. Each variant was tested for association with T2D individuals, and, increase power, most...

10.1038/sdata.2017.179 article EN cc-by Scientific Data 2017-12-19

Inducible pluripotent stem cell–derived human β-like cells (BLCs) hold promise for both therapy and disease modeling, but their generation remains challenging functional analyses beyond transcriptomic morphological assessments remain limited. Here, we validate an approach using multicellular single-cell electrophysiological tools to evaluate function of BLCs from pioneer protocols that can be easily adapted more differentiated BLCs. The multi-electrode arrays (MEAs) measuring the...

10.2337/db23-0776 article EN Diabetes 2024-05-22

Heterozygous glucokinase (GCK) mutations cause a subtype of maturity-onset diabetes the young (GCK-MODY). Over 600 GCK have been reported which ∼65% are missense. In many cases co-segregation has not established and despite importance functional studies in ascribing pathogenicity for missense variants these only performed <10% mutations. The aim this study was to determine minimum prevalence GCK-MODY amongst diabetic subjects Slovakia by sequencing 100 Slovakian probands with phenotype...

10.1371/journal.pone.0034541 article EN cc-by PLoS ONE 2012-04-06

Maturity onset diabetes of the young (MODY) is a hereditary form mellitus presenting at childhood or adolescence, which eventually leads to pancreatic β-cells dysfunction. The underlying genetic basis MODY disorders haploinsufficiency, where loss-of-function mutations in single allele cause diabetic phenotype heterozygous patients. MODY1 type disorder resulting from mutation transcription factor hepatocyte nuclear 4 alpha (HNF4α). In order establish human based model study MODY1, we...

10.1016/j.scr.2018.06.013 article EN cc-by-nc-nd Stem Cell Research 2018-06-26

Recent studies have reported significant advances in the differentiation of human pluripotent stem cells to clinically relevant cell types such as insulin producing beta-like and motor neurons. However, many current protocols lead heterogeneous cultures containing other than targeted fate. Genetically modified reporting expression specific genes are great value for protocol optimization purification populations from cultures. Here we present generation induced (iPSC) lines with a GFP...

10.1016/j.scr.2018.04.010 article EN cc-by-nc-nd Stem Cell Research 2018-04-23

Directed differentiation of stem cells offers a scalable solution to the need for human cell models recapitulating islet biology and T2D pathogenesis. We profiled mRNA expression at 6 stages an induced pluripotent (iPSC) model endocrine pancreas development from 2 donors, characterized distinct transcriptomic profiles associated with each stage. Established regulators endodermal lineage commitment, such as SOX17 (log2 fold change [FC] compared iPSCs = 14.2, p-value 4.9 × 10−5) pancreatic...

10.1080/19382014.2016.1182276 article EN cc-by Islets 2016-04-18

Type 2 diabetes is a global problem, and current ineffective therapeutic strategies pave the way for novel treatments like small molecular activators targeting glucokinase (GCK). GCK activity fundamental to beta cell hepatocyte glucose metabolism, heterozygous activating inactivating mutations cause hyperinsulinemic hypoglycemia (HH) maturity onset of young (MODY) respectively. Over 600 naturally occurring have been reported, whereas only 13 are documented date. We report two HH (V389L...

10.1074/jbc.m111.223362 article EN cc-by Journal of Biological Chemistry 2011-03-30

Wolfram syndrome (WFS) is a rare disorder characterised by childhood-onset diabetes mellitus and progressive optic atrophy. Most patients have variants in the WFS1 gene. We undertook functional studies of correlated these with protein expression phenotype.9 clinical diagnosis WFS were studied quantitative PCR for markers endoplasmic reticulum (ER) stress immunoblotting fibroblast extracts expression. Luciferase reporter assay was used to assess ATF-6 dependent unfolded response (UPR)...

10.1136/jmedgenet-2020-107257 article EN cc-by Journal of Medical Genetics 2021-05-18

Liver disease is a major cause of premature death. Oxidative stress in the liver represents key driver. Compounds, such as dimethyl fumarate (DMF), can activate antioxidant response and are used clinically to treat disease. In this study, we tested protective properties DMF before or after paracetamol exposure. Following administration, Nrf2 nuclear translocation was tracked at single-cell level target gene transactivation confirmed. Next, were examined following Transcriptomic biochemical...

10.1016/j.isci.2021.102552 article EN cc-by-nc-nd iScience 2021-05-19

Type 2 Diabetes (T2D) constitutes a global health burden. Efforts to uncover predisposing genetic variation have been considerable, yet detailed knowledge of the underlying pathogenesis remains poor. Here, we constructed T2D phenotypic-linkage network (T2D-PLN), by integrating diverse gene functional information that highlight genes, which when disrupted in mice, elicit similar T2D-relevant phenotypes. Sensitising phenotypes enabled significant convergence be detected between genes...

10.1371/journal.pcbi.1005816 article EN cc-by PLoS Computational Biology 2017-10-23
Coming Soon ...